Sfoglia per Rivista CANCER TREATMENT REVIEWS
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies
2015-01-01 De Bari, Berardino; Filippi, Andrea Riccardo; Mazzola, Rosario; Bonomo, Pierluigi; Trovò, Marco; Livi, Lorenzo; Alongi, Filippo
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)
2018-01-01 Imbimbo, M.; Ottaviano, M.; Vitali, M.; Fabbri, A.; Leuzzi, G.; Fiore, M.; Franceschini, D.; Pasello, G.; Perrino, M.; Schiavon, M.; Pruneri, G.; Dei Tos, A. P.; Sangalli, C.; Garassino, M. C.; Berardi, R.; Alessi, A.; Calareso, G.; Petrini, I.; Scorsetti, M.; Scotti, V.; Rosso, L.; Rea, F.; Pastorino, U.; Casali, P. G.; Ramella, S.; Ricardi, U.; Abate-Daga, L.; Torri, V.; Trama, A.; Palmieri, G.; Marino, M.; Zucali, P. A.; Alloisio, M; Apolone, G; Ardizzoni, A; Benvenuti, Mauro Roberto; Berruti, A; Breda, C; Buzzoni, C; Calabrese, F; Caraceni, A; Cardillo, G; Casadio, C; Cassi, E; Caterino, M; Cecere, Fl; Chiti, A; Crippa, A; Curcio, C; De Braud, F; De Pas, T; Di Tommaso, L; Evoli, A; Facciolo, F; Galli, G; Lopez, I; Lo Russo, G; Luisella, S; Luzzi, L; Mantovani, C; Marchianò, A; Margaritora, S; Monaco, R; Morandi, U; Novellino, L; Piras, Mt; Porcu, L; Priola, A; Proto, C; Battista Ratto, G; Rena, O; Rinaldi, S; Roca, E; Rocco, G; Ruffini, E; Signorelli, D; Solli, P; Spaggiari, L; Stefani, A; Veltri, A; Vespro, V; Zilembo, N.
Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside
2015-01-01 Cella, Chiara Alessandra; Minucci, Saverio; Spada, Francesca; Galdy, Salvatore; Elgendy, Mohamed; Ravenda, Paola Simona; Zampino, Maria Giulia; Murgioni, Sabina; Fazio, Nicola
Extreme hypofractionation for early prostate cancer: Biology meets technology
2016-01-01 De Bari, Berardino; Arcangeli, Stefano; Ciardo, Delia; Mazzola, Rosario; Alongi, Filippo; Russi, Elvio G.; Santoni, Riccardo; Magrini, Stefano M.; Jereczek-Fossa, Barbara A.
Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes
2020-01-01 Claps, M.; Mennitto, A.; Guadalupi, V.; Sepe, P.; Stellato, M.; Zattarin, E.; Gillessen, S. S.; Sternberg, C. N.; Berruti, A.; De Braud, F. G. M.; Verzoni, E.; Procopio, G.
Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs
2018-01-01 Cavalieri, S.; Rivoltini, L.; Bergamini, C.; Locati, L. D.; Licitra, L.; Bossi, P.
Is DNA repair a potential target for effective therapies against malignant mesothelioma?
2020-01-01 Fuso Nerini, I.; Roca, E.; Mannarino, L.; Grosso, F.; Frapolli, R.; D'Incalci, M.
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectives
2017-01-01 Lambrescu, Ioana; Fica, Simona; Martins, Diana; Spada, Francesca; Cella, Chiara; Bertani, Emilio; Rubino, Manila; Gibelli, Bianca; Grana, Chiara; Bonomo, Guido; Funicelli, Luigi; Ravizza, Davide; Pisa, Eleonora; Zerini, Dario; Ungaro, Antonio; Fazio, Nicola
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives
2023-01-01 Berruti, A.; Bracarda, S.; Caffo, O.; Cortesi, E.; D'Angelillo, R.; Del Re, M.; Facchini, G.; Pappagallo, G.; Procopio, G.; Sabbatini, R.; Santini, D.
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis
2017-01-01 Roca, Elisa; Gurizzan, Cristina; Amoroso, Vito; Vermi, William; Ferrari, Vittorio Domenico; Berruti, Alfredo
Predicting the risk of bone metastasis in prostate cancer
2014-01-01 Briganti, A; Suardi, N; Gallina, A; Abdollah, F; Novara, G; Ficarra, V; Montorsi, F
The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach
2014-01-01 Cacicedo, J.; Navarro, A.; Alongi, F.; Gomez de Iturriaga, A.; del Hoyo, O.; Boveda, E.; Casquero, F.; Perez, J. F.; Bilbao, P.
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus
2021-01-01 Jereczek-Fossa, B. A.; Marvaso, G.; Zaffaroni, M.; Gugliandolo, S. G.; Zerini, D.; Corso, F.; Gandini, S.; Alongi, F.; Bossi, A.; Cornford, P.; De Bari, B.; Fonteyne, V.; Hoskin, P.; Pieters, B. R.; Tree, A. C.; Arcangeli, S.; Fuller, D. B.; Franzese, C.; Hannoun-Levi, J. -M.; Janoray, G.; Kerkmeijer, L.; Kwok, Y.; Livi, L.; Loi, M.; Miralbell, R.; Pasquier, D.; Pinkawa, M.; Scher, N.; Scorsetti, M.; Shelan, M.; Toledano, A.; van As, N.; Vavassori, A.; Zilli, T.; Pepa, M.; Ost, P.
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis
2019-01-01 Rebelatto, T. F.; Falavigna, M.; Pozzari, M.; Spada, F.; Cella, C. A.; Laffi, A.; Pellicori, S.; Fazio, N.
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone.
2013-01-01 Pia, A; Vignani, F; Attard, G; Tucci, M; Bironzo, P; Scagliotti, G; Arlt, W; Terzolo, M; Berruti, Alfredo
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis
2018-01-01 Pozzari, M; Maisonneuve, P; Spada, F; Berruti, A; Amoroso, V; Cella, CHIARA ALESSANDRA; Laffi, A; Pellicori, S; Bertani, E; Fazio, N.
The role of systemic therapy in the management of sinonasal cancer: A critical review
2015-01-01 Bossi, P; Saba, Nf; Vermorken, Jb; Strojan, P; Pala, L; de Bree, R; Rodrigo, Jp; Lopez, F; Hanna, Ey; Haigentz, M; Takes, Rp; Slootweg, Pj; Silver, Ce; Rinaldo, A; Ferlito, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies | 1-gen-2015 | De Bari, Berardino; Filippi, Andrea Riccardo; Mazzola, Rosario; Bonomo, Pierluigi; Trovò, Marco; Livi, Lorenzo; Alongi, Filippo | |
| Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) | 1-gen-2018 | Imbimbo, M.; Ottaviano, M.; Vitali, M.; Fabbri, A.; Leuzzi, G.; Fiore, M.; Franceschini, D.; Pasello, G.; Perrino, M.; Schiavon, M.; Pruneri, G.; Dei Tos, A. P.; Sangalli, C.; Garassino, M. C.; Berardi, R.; Alessi, A.; Calareso, G.; Petrini, I.; Scorsetti, M.; Scotti, V.; Rosso, L.; Rea, F.; Pastorino, U.; Casali, P. G.; Ramella, S.; Ricardi, U.; Abate-Daga, L.; Torri, V.; Trama, A.; Palmieri, G.; Marino, M.; Zucali, P. A.; Alloisio, M; Apolone, G; Ardizzoni, A; Benvenuti, Mauro Roberto; Berruti, A; Breda, C; Buzzoni, C; Calabrese, F; Caraceni, A; Cardillo, G; Casadio, C; Cassi, E; Caterino, M; Cecere, Fl; Chiti, A; Crippa, A; Curcio, C; De Braud, F; De Pas, T; Di Tommaso, L; Evoli, A; Facciolo, F; Galli, G; Lopez, I; Lo Russo, G; Luisella, S; Luzzi, L; Mantovani, C; Marchianò, A; Margaritora, S; Monaco, R; Morandi, U; Novellino, L; Piras, Mt; Porcu, L; Priola, A; Proto, C; Battista Ratto, G; Rena, O; Rinaldi, S; Roca, E; Rocco, G; Ruffini, E; Signorelli, D; Solli, P; Spaggiari, L; Stefani, A; Veltri, A; Vespro, V; Zilembo, N. | |
| Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside | 1-gen-2015 | Cella, Chiara Alessandra; Minucci, Saverio; Spada, Francesca; Galdy, Salvatore; Elgendy, Mohamed; Ravenda, Paola Simona; Zampino, Maria Giulia; Murgioni, Sabina; Fazio, Nicola | |
| Extreme hypofractionation for early prostate cancer: Biology meets technology | 1-gen-2016 | De Bari, Berardino; Arcangeli, Stefano; Ciardo, Delia; Mazzola, Rosario; Alongi, Filippo; Russi, Elvio G.; Santoni, Riccardo; Magrini, Stefano M.; Jereczek-Fossa, Barbara A. | |
| Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes | 1-gen-2020 | Claps, M.; Mennitto, A.; Guadalupi, V.; Sepe, P.; Stellato, M.; Zattarin, E.; Gillessen, S. S.; Sternberg, C. N.; Berruti, A.; De Braud, F. G. M.; Verzoni, E.; Procopio, G. | |
| Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs | 1-gen-2018 | Cavalieri, S.; Rivoltini, L.; Bergamini, C.; Locati, L. D.; Licitra, L.; Bossi, P. | |
| Is DNA repair a potential target for effective therapies against malignant mesothelioma? | 1-gen-2020 | Fuso Nerini, I.; Roca, E.; Mannarino, L.; Grosso, F.; Frapolli, R.; D'Incalci, M. | |
| Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectives | 1-gen-2017 | Lambrescu, Ioana; Fica, Simona; Martins, Diana; Spada, Francesca; Cella, Chiara; Bertani, Emilio; Rubino, Manila; Gibelli, Bianca; Grana, Chiara; Bonomo, Guido; Funicelli, Luigi; Ravizza, Davide; Pisa, Eleonora; Zerini, Dario; Ungaro, Antonio; Fazio, Nicola | |
| nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives | 1-gen-2023 | Berruti, A.; Bracarda, S.; Caffo, O.; Cortesi, E.; D'Angelillo, R.; Del Re, M.; Facchini, G.; Pappagallo, G.; Procopio, G.; Sabbatini, R.; Santini, D. | |
| Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis | 1-gen-2017 | Roca, Elisa; Gurizzan, Cristina; Amoroso, Vito; Vermi, William; Ferrari, Vittorio Domenico; Berruti, Alfredo | |
| Predicting the risk of bone metastasis in prostate cancer | 1-gen-2014 | Briganti, A; Suardi, N; Gallina, A; Abdollah, F; Novara, G; Ficarra, V; Montorsi, F | |
| The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach | 1-gen-2014 | Cacicedo, J.; Navarro, A.; Alongi, F.; Gomez de Iturriaga, A.; del Hoyo, O.; Boveda, E.; Casquero, F.; Perez, J. F.; Bilbao, P. | |
| Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus | 1-gen-2021 | Jereczek-Fossa, B. A.; Marvaso, G.; Zaffaroni, M.; Gugliandolo, S. G.; Zerini, D.; Corso, F.; Gandini, S.; Alongi, F.; Bossi, A.; Cornford, P.; De Bari, B.; Fonteyne, V.; Hoskin, P.; Pieters, B. R.; Tree, A. C.; Arcangeli, S.; Fuller, D. B.; Franzese, C.; Hannoun-Levi, J. -M.; Janoray, G.; Kerkmeijer, L.; Kwok, Y.; Livi, L.; Loi, M.; Miralbell, R.; Pasquier, D.; Pinkawa, M.; Scher, N.; Scorsetti, M.; Shelan, M.; Toledano, A.; van As, N.; Vavassori, A.; Zilli, T.; Pepa, M.; Ost, P. | |
| Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis | 1-gen-2019 | Rebelatto, T. F.; Falavigna, M.; Pozzari, M.; Spada, F.; Cella, C. A.; Laffi, A.; Pellicori, S.; Fazio, N. | |
| Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. | 1-gen-2013 | Pia, A; Vignani, F; Attard, G; Tucci, M; Bironzo, P; Scagliotti, G; Arlt, W; Terzolo, M; Berruti, Alfredo | |
| Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis | 1-gen-2018 | Pozzari, M; Maisonneuve, P; Spada, F; Berruti, A; Amoroso, V; Cella, CHIARA ALESSANDRA; Laffi, A; Pellicori, S; Bertani, E; Fazio, N. | |
| The role of systemic therapy in the management of sinonasal cancer: A critical review | 1-gen-2015 | Bossi, P; Saba, Nf; Vermorken, Jb; Strojan, P; Pala, L; de Bree, R; Rodrigo, Jp; Lopez, F; Hanna, Ey; Haigentz, M; Takes, Rp; Slootweg, Pj; Silver, Ce; Rinaldo, A; Ferlito, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile